Project Grant HT94252510553
Award Date
7/1/25
Completion Date
6/30/29
Dollars Obligated
$5.1M
Federal Agency
Defense Health Agency
Awardee
149 Bio LLC (PUXSSH1GHNF7)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Miami, FL 33136, USA
Similar Awards
This federal Project Grant award, with a total funding amount of $999,972.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research to study urine macrophages in lupus nephritis, with the goal of shedding light on kidney disease processes. The research is being conducted by The Feinstein Institutes for Medical Research, a leading non-profit medical research organization, from July 1, 2025 through June...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
This $999,392 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research initiatives at the University of Houston System. The funding will be used to conduct research on PRMT5 in lupus nephritis, with a performance period from September 1, 2025 through August 31, 2029. The Military Medical Research and Development program focuses on transforming healthcare for military service...
The federal Project Grant award, totaling $6,663,794.00 and effective September 30, 2024, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the "PRECISIE RTD TRIAL: PRECISION WITH RETURN-TO-DUTY DECISIONS IN THE MILITARY" research initiative, which aims to transform healthcare for military service members. The primary awardee, The Geneva Foundation, will conduct advanced biomedical research and...
This federal Project Grant award, valued at $1,306,778 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on investigating the "Immunologic Drivers of Lineage Bias in TP53-mutant Acute Leukemia" at the University of Chicago. The research aims to transform healthcare for military service members and the broader public through innovative and impactful scientific...
Yale University received a $1,618,571 project grant award from the Defense Health Agency through the Military Medical Research and Development federal grant program (CFDA 12.420). The award will fund research from June 2023 through May 2027 to investigate the role of immune cell-podocyte crosstalk in the pathogenesis of APOL1-FSGS and proteinuric kidney disease. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The Defense Health Agency has awarded a $1,674,999.00 Project Grant to Yale University under the Military Medical Research and Development program (CFDA 12.420). The grant is for the "PERTURBOMICS IDENTIFICATION OF CRITICAL GENETIC TARGETS IN NK CELLS FOR BREAST CANCER THERAPY" project, which will be conducted from September 1, 2023 to August 31, 2026. The funding will support basic, applied, and advanced biomedical research to transform healthcare for service members and the public...
This Federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $504,678 in funding to the Mountain Home Research & Education Corporation for a research project titled "LONG NONCODING RNAS IN VIRAL LYMPHOMAS". The award period runs from September 30, 2023 to September 29, 2025. The project aims to conduct basic, translational, and clinical research related to military medicine, with a focus on...
Yale University received a $1,731,409 project grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from June 2023 through May 2027 to investigate the role of immune cell-podocyte crosstalk in the pathogenesis of APOL1-FSGS and proteinuric kidney disease. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The federal Project Grant award of $422,299.00 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to the Texas A&M University System Health Science Center is for a project titled "INHIBITING RENAL LYMPHATIC EXPANSION TO MITIGATE NEPHROTIC SYNDROME". The grant, awarded on February 1, 2025, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research will...